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Abstract 
Human immunodeficiency virus type 1 (HIV-1) and other lentiviruses have 
developed latency as one mechanism to evade the host immune response. As a 
consequence, a subset of these viruses life-long latency, effectively preventing the 
eradication of HIV-1 infection. Two types of latency have been proposed: pre-integration 
and post-integration latency. In pre-integration latency, the pre-integration complex (PIC) 
composed of newly formed viral DNA, integrase, Vpr, and matrix protein, is prevented 
from entering the nucleus by host cellular factors. In post-integration latency, the PIC 
migrates to the nucleus and integrates into the genomic DNA, where it remains as 
dormant provirus for an indefinite period of time. We recently reported that mucosal 
administration of low dose cell-associated feline immunodeficiency virus (FIV) (102 and 
103 infected cells) promotes viral latency in peripheral blood mononuclear cells (PBMC) 
and tissue lymphocytes that can be reactivated by in vitro cell stimulation. The current 
study investigates the type of infection occurring in high- or low-dose cell-associated FIV 
groups using polymerase chain reaction (PCR). Blood and tissue samples were analyzed 
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for three different DNA products of FIV infection. Early stage products of reverse 
transcriptase (163 bp), intermediate stage products (542 bp), as well as late circle junction 
products (967 bp) of FIV were seen in high-dose groups (104~106 infected cells) whereas 
early reverse transcription products were the only, or primary, form detected in low-dose 
groups (102~103 infected cells). This is consistent with the development of viral latency 
in cats challenged with low numbers of infected cells.  Because we identified early 
transcripts in samples from latently infected cats, our findings support one of two 
theories.  (1) Transport of the pre-integration complex into the nucleus is inhibited 
resulting in pre-integration latency.  (2) Late transcription is impaired resulting in post-
integration latency.   Our data provides evidence that latent infection occurs following 
mucosal exposure to low-dose FIV and raises the concern that some individuals exposed 
to low amounts of HIV may also become latently infected.  This work helps to focus 
further investigations into the mechanisms of lentiviral latency. 
 
Introduction 
 Human immunodeficiency virus (HIV) is the causative agent of AIDS and the 
largest epidemic in the world today. One of the largest challenges in combating HIV is 
the presence of latent viral reservoirs. The majority of HIV infected individuals maintain 
a productive infection and, in the absence of treatment, often progress to AIDS.  In 
contrast, some individuals harbor the virus for months to years without showing 
symptoms, and a very small subset of exposed individuals remain seronegative 
indefinitely [9]. However, even in patients that progress to AIDS, there is ongoing 
development of latent (quiescent) as well as lytic (productive) virus.  Antiretroviral 
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treatments such as the combination of multiple drugs in highly active anti-retroviral 
therapy (HAART) can dramatically reduce productive HIV replication but are often 
ineffective against latent virus that re-emerges rapidly after the cessation of therapy. 
Because latency is a bane for the treatment of HIV, many investigators are actively 
seeking model systems to better understand the mechanisms of viral latency. 
 Feline immunodeficiency virus (FIV) is a retrovirus often used as an animal 
model of HIV. Although more distant from HIV than other primate lentivirus such as 
simian immunodeficiency virus (SIV), it shares much of its genetic structure and 
pathogenesis with HIV, and thus is a well-accepted animal model for HIV transmission, 
immunopathogenesis, and vaccine studies [2]. FIV uses CD134 and CXCR4 as the 
binding and entry receptor, rather than CD4 and CCR5/CXCR4 as does HIV, but 
ultimately infects a similar subtype of activated lymphocytes as does HIV [4].  FIV is 
divided into 5 clades (A-E) [2]. The present study employs the NCSU1 strain of FIV, a 
clade A virus. FIV exhibits an HIV-like tropism at cellular and tissue levels, resulting in 
an acute phase with plasma viremia and decreased CD4/CD8 ratios, an asymptomatic 
period marked by low-level viremia and steady decline of CD4+ cells, and finally 
development of feline AIDS, in which the cat is left vulnerable to opportunistic infections 
[2,4,7].   
 Using the FIV model, the Burkhard lab has recently demonstrated that the 
development of latent infection is at least partly dose-dependent. They reported that 
mucosal administration of low doses of cell-associated virus (102-103) promotes latency 
in the host, while exposure to higher numbers of cell-associated virus results in 
productive infection [1]. The goal of the current study is to identify whether early and late 
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viral transcripts are produced in latently infected cats.  The information obtained will help 
focus further investigations into the mechanism(s) of lentiviral latency. 
 Previous studies have described several DNA intermediates produced by FIV at 
distinct points of its replication within the host cell [3,4,7,11]. After entering a host cell, 
the process of reverse transcription from RNA to DNA begins immediately, and can be 
detected by using LTR-LTR primers that amplify an early DNA product of about 163 
base pairs (bp) in length. After reverse transcription, the pre-integration complex (PIC) 
composed of viral cDNA, integrase, Vpr, and matrix proteins migrates to the nucleus and 
integrates into the feline’s genome. This is detected by amplifying an LTR-Gag product 
of 542 bp. The third DNA intermediate of interest is an extrachromosomal loop (967 bp) 
detected by using Env-Gag primers, that indicates productive infection (Fig. 1).  
 
 
Extrachromosomal Loops – primers link and amplify only those DNA products which have left the integrated state during a 
productive infection. Also known as “LTR loops” or “circle junctions.” 
LTR LTR 
Env Pol Gag 5’ 3’ 
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Figure 1 – The directionality of the Env-s/Gag-as primers prevents accidental replication of the integrated 
virus, ensuring that the amplified product indicates productive infection. This concept has been previously 
described using similar figures in Frey et al, 2001 and Joshi et al, 2004. 
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Materials/Methods 
Samples were obtained from a previously described study cohort [1].  Briefly, 
eighteen female cats were obtained from Liberty Labs and were housed and cared for in 
accordance with the standards of the American Association of Accreditation of 
Laboratory Animal Care and the Institutional Animal Care and Use Committee. Cats 
were grouped (3 cats/group) and inoculated at 4 months of age with 106 naive CD4+ T 
cells or with serial dilutions of FIV NCSU1-infected CD4+ T cells in 50 μL of 
lymphocyte medium. NCSU1 is a clade A pathogenic FIV that does not produce high 
plasma viremia after mucosal transmission but induces high provirus levels and 
progressive immune dysregulation. Spleen, small intestinal intraepithelial lymphocytes 
(IEL) and lamina propria lymphocytes (LPL), popliteal lymph node (PLN), mesenteric, 
lymph node (MLN), medial iliac lymph node (ILN), and peripheral mononuclear blood 
cells (PBMC) were harvested at 12 weeks post-infection, processed as previously 
described [1] and stored at 4oC as DNA until used for this study. 
 DNA samples were analyzed on a 1% agarose gel for degradation.  No noticeable 
degradation was detected. The concentration of nucleic acids in each sample was then 
obtained by spectrophotometer (Nanodrop®, Wilmington, Delaware) and the volume 
standardized so that 100 ng of template DNA would be present in each PCR well.  
The primers, first described in Rottman, et al (1995) [8] and later optimized by 
others [4,7], amplify three distinct DNA intermediates of FIV infection. The early 
product of reverse transcriptase, indicative of virus entry, was amplified by LTR-sense 
(5'-GCG CTA GCA GCT GCC TAA CCG CAA AAC CAC-3') and LTR-antisense (5'-
GTA TCT GTG GGA GCC TCA AGG GAG AAC TC-3'). The intermediate product, 
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indicative of integration, was amplified by LTR-sense and Gag-antisense (5'-CGC CCC 
TGT CCA TTC CCC ATG TTG CTG TAG AAT CTC-3'). The third and final product, 
indicative of productive infection, was amplified by Env-sense (5'-GGC AAT GTG GCA 
TGT CTG AAA AAG AGG AGG AAT GAT-3') and Gag-antisense.  
PCR was performed on a Mastercycler Gradient© thermocycler (Eppendorf, 
Germany) using HotStarTaq© Polymerase Master Mix Kit (Qiagen, Germany). The 
thermal profile included an initial 15 min activation step at 95oC, followed by 40 cycles 
each containing a 45 sec denaturation step at 95oC, 45 sec annealing step at 60oC, and 1 
min lengthening step at 72oC. The profile was completed with a 15 min incubation step at 
72oC, after which the products were stored at 4oC until analysis. These conditions were 
altered during optimization for two particular cases.  First, to amplify the product with 
higher specificity, the LTR-LTR primer pair was amplified using a 1X final 
concentration of the Q-solution© provided in the HotStarTaq kit.  Secondly, because of 
the particularly low melting temperatures of the primers, the Env-Gag product was 
amplified with a 57oC annealing step. After amplification, all products were separated 
according to size on 1% agarose gels for analysis, using SeaKem© agarose powder 
(Cambrex, Rockland, Maine) and ethidium bromide. The gels were visualized by UV 
digital photography on a GelDoc2000© machine (BioRad, Hercules, California) using 
Kodak 1-D© software (Kodak, Rochester, New York). 
 
Results 
The initial protocol used real-time PCR that requires use of a reference dye to 
quantify PCR copies.  Through multiple optimization steps, it was found that some of the 
primer pairs (especially Env-sense and Gag-antisense) had a strong interaction with the 
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real-time reference dye that inhibited an efficient or specific PCR reaction.  This 
approach was abandoned (data not shown), and standard hot-start PCR was then used to 
perform the remainder of the analysis. 
Early Reverse Transcriptase Product (LTR-LTR) 
Cats inoculated with high numbers of cell-associated virus developed lytic, 
progressive infection in multiple tissues [1].  These findings were consistent with the 
disseminated tissue distribution of LTR-LTR products.  The LTR-LTR product was 
routinely identified in most tissues isolated from the cats inoculated with high numbers 
(106-104) of FIV infected cells (Fig. 2).  However, two cats (B5 and Z7) within the high 
dose group exhibited the LTR-LTR product in only two tissues each (ILN and LPL in cat 
B5, ILN and Spleen in cat Z7). We were also able to detect LTR-LTR products in at least 
one tissue from each cat inoculated with low numbers (103-102) of cell-associated virus.  
 
  
 
 
 
 
Figure 2 – PCR products of the LTR-
LTR primers are shown according to 
tissue type and cat ID. The 
concentration of cell-associated virus 
in the inoculum decreases from left to 
right. A 100 bp marker was used to 
identify the correct bands (not 
shown).  LTR-LTR product is 163 bp. 
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Cats inoculated with high numbers of cell-associated virus developed lytic, 
progressive infection in multiple tissues [1].  These findings were consistent with the 
disseminated tissue distribution of LTR-LTR products.  Although we did not attempt to 
quantify the LTR-LTR product in this study, standardized amounts of template DNA 
were used in each PCR well, along with identical methods of preparing and viewing 
agarose gels.  In cats with high dose exposure and progressive lytic infection, very bright 
bands, which likely represent a substantial amount of PCR product, are seen in all tissues 
except the LPL.  In contrast, bands are weak or absent in most tissues for latently infected 
cats with the single exception of the LPL. 
 
Late Reverse Transcriptase Product (LTR-Gag) 
 The LTR-Gag primers amplify a late reverse transcriptase product, that has been 
previously used to detect virus integration into the host genome (a crucial step in 
productive infection). The LTR-Gag product amplified in at least one tissue within each 
of the high dose cats, although it was not present in all samples (Fig. 3). This supports the 
previous findings of productive infection in these cats [1].  While seven of the high dose 
cats produced the late reverse-transcriptase product in at least three tissues, cats B5 and 
Z7 only exhibited the LTR-Gag product in the LPL.  
 In contrast, we were only able to detect the LTR-Gag product in two of the low 
dose cats: in the MLN of cat C6, and in the MLN, ILN, IEL, and LPL of cat F4.  The 
paucity of late reverse transcriptase product in the low dose group (103-102) is consistent 
with the absence of detectable infection in these latently infected cats.   
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Figure 3 – PCR products of the LTR-
Gag primers are shown according to 
tissue type and cat ID. The 
concentration of cell-associated virus 
in the inoculum decreases from left to 
right. A 100 bp marker was used to 
identify the correct bands (not 
shown).  LTR-Gag product is 542 bp. 
 
 
 
 
  
 The LTR-Gag product was not uniformly distributed across tissue types.   Unlike 
the LTR-LTR product, a specific pattern of distribution could not be detected.  PBMC 
and ILN tissues showed positive bands in four cats each, whereas the IEL and MLN 
exhibited bands in eight and seven cats, respectively. The remaining tissues (spleen, PLN, 
and LPL) displayed bands in five to six cats each. 
 
LTR Loops or “Circle Junctions” (Env-Gag Product) 
 In support of previous findings [1], the extrachromosomal loops, which indicate 
productive infection, were not found in any of the seven tissues for any of the six cats 
exposed to low doses (103-102) of cell-associated virus (Fig. 4). In contrast, a majority of 
high dose cats (106-104) exhibited LTR loops in three or more tissues.  
 The complete absence of detectable Env-Gag products in B5 and Z7 was 
unexpected, as both had been exposed to high doses of cell-associated virus. However, 
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because of the sequential nature of these three DNA products within an infection, the lack 
of Env-Gag products correlates with the paucity of LTR-Gag product in these animals. 
 
     
Figure 4 – PCR products of the 
Env-Gag primers are shown 
according to tissue type and cat ID. 
The concentration of cell-associated 
virus in the inoculum decreases 
from left to right. A 1 kb marker 
(not shown) was used to identify the 
correct band size of 967 bp. 
 
 
 
 
 The late product was most prevalent in the PBMC, where seven of nine of the 
high-dose cats displayed very bright bands. Similarly, the spleen samples elicited bright 
Env-Gag bands in six of nine of the cats, and MLN displayed six bands, albeit less bright 
in appearance. The PLN, ILN, and IEL samples each amplified in only four cats. No Env-
Gag product amplified to a detectable degree in the LPL samples.  
  
Discussion 
 In this study, we examined samples from a cohort of cats previously described to 
have either lytic or latent FIV infection [1]. We hypothesized that when exposed to a low 
viral load, these low-dose cats would tend to develop a pre-integration latency, where the 
PIC is held in the cytoplasm preventing the virus from entering the nucleus for immediate 
integration.  We found that samples from low dose, latently infected cats contained early 
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(LTR-LTR) transcription products, infrequent intermediate reverse transcriptase products 
(LTR-Gag), and the complete absence of Env-Gag LTR loops.  The absence of LTR 
loops supports previous inability to detect productive infection in these animals.   The 
occasional presence of LTR-Gag products suggests that, at least in some animals, virus 
was transported into the nucleus and integrated into the genomic DNA.  However, in the 
majority of tissues from most low dose cats, this intermediate product was not detected.   
 This lack of an intermediate product in low dose cats may represent innate 
inhibition of viral DNA transport into the nucleus. In HIV, some have argued that the 
host APOBEC proteins are responsible for an innate restriction process [6], but this has 
not been tested in the FIV system. Others have demonstrated a similar state can be 
induced in FIV infection in vitro by zidovudine (AZT) treatment, a main component of 
HAART [4]. AZT prevents the virus from forming late DNA products of infection, and 
may promote a latent state. However, similar findings would be seen if there was 
inhibition of late stage transcription.   
 Because gut-associate lymphoid tissue (GALT) is a strong and early target for the 
HIV [5], SIV [12], and FIV [2] viruses, infection leads to rapid depletion of lamina 
propria lymphocytes [5,13]. This early and massive depletion of lamina propria 
lymphocytes is not reflected in the lymph nodes or PBMC, the latter of which is 
commonly used to monitor HIV disease progression [5]. The rapid depletion of LPL 
creates an absence of target cells in the gut tissues, which may be the reason that 
detection of all transcription products (LTR-LTR, LTR-Gag, and Env-Gag) was limited 
and/or absent in the LPL of high-dose cats with lytic infections.  Consistent with previous 
studies that have examined early FIV infection and progression to disease, PBMC were 
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infected but not depleted to the point of preventing the amplification of clear Env-Gag 
products. 
 Our findings suggest a basic exposure threshold for the number of cell-associated 
virus (somewhere between 103 and 104) required for FIV to induce a productive infection 
within 12 weeks of exposure at the vaginal mucosa. At lower doses, latency occurs with 
lack of transcription progression to intermediate and late transcripts, especially circle 
junctions, which indicate the presence of active viral replication. Because we did not 
detect intermediate products in most tissues from most cats with latent infection, our data 
most likely supports the hypothesis that exposure to low-dose cell-associated FIV results 
in pre-integration latency. Preliminary work by others in the laboratory has identified a 
potential protein-protein interaction similar to the interaction between APOBEC host 
proteins and the HIV PIC, previously described in Harris and Liddament (2004) [6].  
Those findings support our working hypothesis of pre-integration latency, although 
further research is necessary to identify the exact mechanism of latency, and to exclude 
an AZT-like block of late transcription.    
 In summary, we examined transcriptional DNA intermediates in a cohort of cats 
with latent and lytic FIV infection.  In latently infected cats, we found early, but generally 
not intermediate or late transcription DNA products.  We also found that the gut, 
primarily the lamina propria, was the major target for latent infection in these cats.  This 
data most likely supports our hypothesis that exposure to low numbers of infected cells 
results in pre-integration latency, although it could also be explained by post-integration 
latency via a transcriptional block.  This system provides a new model to examine HIV 
latency.   
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